Cost-effectiveness modelling of use of urea breath test for the management of Helicobacter pylori-related dyspepsia and peptic ulcer in the UK.

Published on Jul 1, 2021in BMJ Open Gastroenterology
· DOI :10.1136/BMJGAST-2021-000685
D. Mark Pritchard30
Estimated H-index: 30
(University of Liverpool),
Jan Bornschein28
Estimated H-index: 28
(University of Oxford)
+ 3 AuthorsPeter Malfertheiner21
Estimated H-index: 21
(Otto-von-Guericke University Magdeburg)
Sources
Abstract
Objective null Clinical data comparing diagnostic strategies in the management of Helicobacter pylori-associated diseases are limited. Invasive and noninvasive diagnostic tests for detecting H. pylori infection are used in the clinical care of patients with dyspeptic symptoms. Modelling studies might help to identify the most cost-effective strategies. The objective of the study is to assess the cost-effectiveness of a ‘test-and-treat’ strategy with the urea breath test (UBT) compared with other strategies, in managing patients with H. pylori-associated dyspepsia and preventing peptic ulcer in the UK. null Design null Cost-effectiveness models compared four strategies: ‘test-and-treat’ with either UBT or faecal antigen test (FAT), ‘endoscopy-based strategy’ and ‘symptomatic treatment’. A probabilistic cost-effectiveness analysis was performed using a simulation model in order to identify probabilities and costs associated with relief of dyspepsia symptoms (over a 4-week time horizon) and with prevention of peptic ulcers (over a 10-year time horizon). Clinical and cost inputs to the model were derived from routine medical practice in the UK. null Results null For relief of dyspepsia symptoms, ‘test-and-treat’ strategies with either UBT (€526/success) and FAT (€518/success) were the most cost-effective strategies compared with ‘endoscopy-based strategy’ (€1317/success) and ‘symptomatic treatment’ (€1 029/success). For the prevention of peptic ulcers, ‘test-and-treat’ strategies with either UBT (€208/ulcer avoided/year) or FAT (€191/ulcer avoided/year) were the most cost-effective strategies compared with ‘endoscopy-based strategy’ (€717/ulcer avoided/year) and ‘symptomatic treatment’ (€651/ulcer avoided/year) (1 EUR=0,871487 GBP at the time of the study). null Conclusion null ‘Test-and-treat’ strategies with either UBT or FAT are the most cost-effective medical approaches for the management of H. pylori-associated dyspepsia and the prevention of peptic ulcer in the UK. A ‘test-and-treat’ strategy with UBT has comparable cost-effectiveness outcomes to the current standard of care using FAT in the UK.
References39
Newest
#1Ren-Jie GongH-Index: 1
#2Canxia XuH-Index: 8
Last. Xiaoming Liu (CSU: Central South University)H-Index: 85
view all 4 authors...
Polymerase chain reaction-based tests for detecting Helicobacter pylori clarithromycin resistance in stool samples: A meta-analysis
1 CitationsSource
#1Ariel BeresniakH-Index: 1
#2Peter Malfertheiner (LMU: Ludwig Maximilian University of Munich)H-Index: 21
Last. Javier P. Gisbert (UAM: Autonomous University of Madrid)H-Index: 102
view all 6 authors...
BACKGROUND: Data from clinical trials comparing Helicobacter pylori (H. pylori) management strategies in patients with dyspepsia are limited. Cost-effectiveness simulation models might help to identify the optimal strategy. OBJECTIVE: To assess the cost-effectiveness of the H. pylori "Test and Treat" (T&T) strategy including the use of urea breath test (UBT) vs symptomatic treatment (ST) and vs upper gastrointestinal endoscopy (UGE) as a first procedure in patients with dyspepsia. METHODS: Three...
9 CitationsSource
: At present, the best rescue therapy for Helicobacter pylori (H. pylori) infection following failure of first-line eradication remains unclear. The Maastricht V/Florence Consensus Report recommends bismuth quadruple therapy, or fluoroquinolone-amoxicillin triple/quadruple therapy as the second-line therapy for H. pylori infection. Meta-analyses have shown that bismuth quadruple therapy and levofloxacin-amoxicillin triple therapy have comparable eradication rates, while the former has more adver...
13 CitationsSource
#2F Ebrahimtabar (Babol University of Medical Sciences)H-Index: 1
#3Vahid Zamani (Babol University of Medical Sciences)H-Index: 4
Last. Mohammad H. Derakhshan (Glas.: University of Glasgow)H-Index: 27
view all 7 authors...
Background: The epidemiology of Helicobacter pylori infection is poorly understood. Aim: To establish the reported regional and national prevalence of H. pylori infection, stratified by age and gender. Methods: All relevant English publications from 2000 to 2017 cited by PubMed and Scopus were retrieved using comprehensive combinations of keywords. The overall prevalence of H. pylori was estimated using both random effect and fixed effect meta-analyses, and presented as prevalence rate (% and 95...
217 CitationsSource
#1Peter Malfertheiner (LMU: Ludwig Maximilian University of Munich)H-Index: 21
Gastric cancer has become a potentially preventable disease through eradication of Helicobacter pylori. However, issues that are associated with “screen and treat” strategies — their effectiveness,...
22 CitationsSource
Background: In order to mitigate potential issues with antibiotic resistance in the treatment of patients with Helicobacter pylori infection, the selection of a therapeutic regimen is optimized by being aware of local eradication rates as well as the patient's medication history and previous diagnoses. Purpose: This study primarily aimed to calculate the eradication rate of H. pylori infection in the New York Metropolitan area when using clarithromycin-based triple therapy per the dosing instruc...
7 CitationsSource
#1Hey-Long Ching (Royal Hallamshire Hospital)H-Index: 6
#2Melissa F Hale (Royal Hallamshire Hospital)H-Index: 10
Last. Mark E. McAlindon (Royal Hallamshire Hospital)H-Index: 30
view all 4 authors...
Objective To evaluate the diagnostic yield of investigating dyspepsia with oesophagogastroduodenoscopy (OGD) with or without mucosal biopsy. Design Retrospective service evaluation study. Setting Two teaching hospitals: The Royal Hallamshire Hospital and Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, UK. Patients 500 patients, 55 years of age and over, who underwent OGD to investigate dyspepsia were included. The study period included a 3-month window. All OGDs wer...
6 CitationsSource
#1James K.Y. Hooi (CUHK: The Chinese University of Hong Kong)H-Index: 1
#2Wan Ying Lai (CUHK: The Chinese University of Hong Kong)H-Index: 1
Last. Siew C. Ng (CUHK: The Chinese University of Hong Kong)H-Index: 79
view all 14 authors...
Background & Aims The epidemiology of Helicobacter pylori infection has changed with improvements in sanitation and methods of eradication. We performed a systematic review and meta-analysis to evaluate changes in the global prevalence of H pylori infection. Methods We performed a systematic search of the MEDLINE and EMBASE databases for studies of the prevalence of H pylori infection published from January 1, 1970 through January 1, 2016. We analyzed data based on United Nations geoscheme regio...
842 CitationsSource
#1Maria Ines Pinto-Sanchez (McMaster University)H-Index: 14
#2Yuhong Yuan (McMaster University)H-Index: 35
Last. Ahmed A. Darwish Hassan (McMaster University)H-Index: 1
view all 4 authors...
Background Functional dyspepsia (FD or non-ulcer dyspepsia) is defined as continuous or frequently recurring epigastric pain or discomfort for which no organic cause can be found. Acid suppressive therapy, including proton pump inhibitors (PPIs), has been proposed as a therapeutic option in FD, but its efficacy remains controversial. While PPIs are generally considered safe and well tolerated, they have been associated with adverse events, especially in the long term. For this reason, decisions ...
68 CitationsSource
#1Peter Malfertheiner (Otto-von-Guericke University Magdeburg)H-Index: 21
#2Francis Mégraud (University of Bordeaux)H-Index: 95
Last. Emad M. El-Omar (UNSW: University of New South Wales)H-Index: 64
view all 18 authors...
Important progress has been made in the management of Helicobacter pylori infection and in this fifth edition of the Maastricht Consensus Report, key aspects related to the clinical role of H. pylori were re-evaluated in 2015. In the Maastricht V/Florence Consensus Conference, 43 experts from 24 countries examined new data related to H. pylori in five subdivided workshops: (1) Indications/Associations, (2) Diagnosis, (3) Treatment, (4) Prevention/Public Health, (5) H. pylori and the Gastric Micr...
1,324 CitationsSource
Cited By0
Newest